Common variation in EMSY and risk of breast and ovarian cancer: A case-control study using HapMap tagging SNPs

BMC Cancer

Volumn 5, Issue , 2005, Pages

  Benusiglio, Patrick R ^a   Lesueur, Fabienne ^a,b   Luccarini, Craig ^a   McIntosh, Joan ^a   Luben, Robert N ^c   Smith, Paula ^c   Dunning, Alison ^a   Easton, Douglas F ^c   Ponder, Bruce A J ^a   Pharoah, Paul D ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; BRCA2 PROTEIN; EMSY PROTEIN; UNCLASSIFIED DRUG; C11ORF30 PROTEIN, HUMAN; NUCLEAR PROTEIN; REPRESSOR PROTEIN; TUMOR PROTEIN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; EXON; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE MAPPING; GENE SILENCING; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; OVARY CANCER; PROGNOSIS; PROMOTER REGION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; UNITED KINGDOM; VALIDATION PROCESS; ALLELE; BIOLOGICAL MODEL; BIOSYNTHESIS; BREAST TUMOR; CASE CONTROL STUDY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOZYGOTE; METABOLISM; MIDDLE AGED; OVARY TUMOR; RISK; STATISTICAL MODEL; TRANSCRIPTION INITIATION;

ADOLESCENT; ADULT; AGED; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HOMOZYGOTE; HUMANS; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; MODELS, GENETIC; MODELS, STATISTICAL; NEOPLASM PROTEINS; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; REPRESSOR PROTEINS; RISK; TRANSCRIPTIONAL ACTIVATION;

EID: 26844463891     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-5-81     Document Type: Article

References (38)

1. Edmondson RJ, Monaghan JM: The epidemiology of ovarian cancer. Int J Gynecol Cancer 2001, 11:423-429.
2. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001, 358:1389-1399.
3. Pharoah PD, Ponder BA: The genetics of ovarian cancer. Best Pract Res Clin Obstet Gynaecol 2002, 16:449-468.
4. Ponder BA: Cancer genetics. Nature 2001, 411:336-341.
5. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group. Br J Cancer 2000, 83:1301-1308.
6. Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MR, Venter DJ, Hopper JL: Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst 2003, 95:448-457.
7. Peto J, Collins N, Barfoot R, Sel S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR: Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 1999, 91:943-949.
8. Easton DF: How many more breast cancer predisposition genes are there? Breast Cancer Res 1999, 1:14-17.
9. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA: Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 2002, 31:33-36.
10. Gayther SA, Russell P, Harrington P, Antoniou AC, Easton DF, Ponder BA: The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes. Am J Hum Genet 1999, 65:1021-1029.
11. Hughes-Davies L, Huntsman D, Ruas M, Fuks F, Bye J, Chin SF, Milner J, Brown LA, Hsu F, Gilks B, Nielsen T, Schulzer M, Chia S, Ragaz J, Cahn A, Linger L, Ozdag H, Cattaneo E, Jordanova ES, Schuuring E, Yu DS, Venkitaraman A, Ponder B, Doherty A, Aparicio S, Bentley D, Theillet C, Ponting CP, Caldas C, Kouzarides T: EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. Cell 2003, 115:523-535.
12. King MC: A novel BRCA2-binding protein and breast and ovarian tumorigenesis. N Engl J Med 2004, 350:1252-1253.
13. Livingston DM: EMSY, a BRCA-2 partner in crime. Nat Med 2004, 10:127-128.
14. Rodriguez C, Hughes-Davies L, Valles H, Orsetti B, Cuny M, Ursule L, Kouzarides T, Theillet C: Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome. Clin Cancer Res 2004, 10:5785-5791.
15. Nordling M, Karlsson P, Wahlstrom J, Engwall Y, Wallgren A, Martinsson T: A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family. Cancer Res 1998, 58:1372-1375.
16. Risch NJ: Searching for genetic determinants in the new millennium. Nature 2000, 405:847-856.
17. Tabor HK, Risch NJ, Myers RM: Opinion: Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 2002, 3:391-397.
18. Rebbeck TR, Ambrosone CB, Bell DA, Chanock SJ, Hayes RB, Kadlubar FF, Thomas DC: SNPs, haplotypes, and cancer: applications in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 2004, 13:681-687.
19. Freedman ML, Penney KL, Stram DO, Le Marchand L, Hirschhorn JN, Kolonel LN, Altshuler D, Henderson BE, Haiman CA: Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort. Hum Mol Genet 2004, 13:2431-2441.
20. Cardon LR, Abecasis GR: Using haplotype blocks to map human complex trait loci. Trends Genet 2003, 19:135-140.
21. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D: The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
22. Pharoah PD, Dunning AM, Ponder BA, Easton DF: Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 2004, 4:850-860.
23. Gibbs RA, Belmont JW, Hardenbol P, Willis TD, Yu F, Yang H, Ch'ang LY, Huang W, Liu B, Shen Y, Tam PK, Tsui LC, Waye MM, Wong JT, Zeng C, Zhang Q, Chee MS, Galver LM, Kruglyak S, Murray SS, Oliphant AR, Montpetit A, Hudson TJ, Chagnon F, Ferretti V, Leboeuf M, Phillips MS, Verner A, Kwok PY, Duan S, Lind DL, Miller RD, Rice JP, Saccone NL, Taillon-Miller P, Xiao M, Nakamura Y, Sekine A, Sorimachi K, Tanaka T, Tanaka Y, Tsunoda T, Yoshino E, Bentley DR, Deloukas P, Hunt S, Powell D, Altshuler D, Gabriel SB, Zhang H, Matsuda I, Fukushima Y, Macer DR, Suda E, Rotimi CN, Adebamowo CA, Aniagwu T, Marshall PA, Matthew O, Nkwodimmah C, Royal CD, Leppert MF, Dixon M, Stein LD, Cunningham F, Kanani A, Thorisson GA, Chakravarti A, Chen PE, Cutler DJ, Kashuk CS, Donnelly P, Marchini J, McVean GA, Myers SR, Cardon LR, Abecasis GR, Morris A, Weir BS, Mullikin JC, Sherry ST, Feolo M, Altshuler D, Daly MJ, Schaffner SF, Qiu R, Kent A, Dunston GM, Kato K, Niikawa N, Knoppers BM, Foster MW, Clayton EW, Wang VO, Watkin J, Gibbs RA, Belmont JW, Sodergren E, Weinstock GM, et al.: The International HapMap Project. Nature 2003, 426:789-796.
24. Dicioccio RA, Song H, Waterfall C, Kimura MT, Nagase H, McGuire V, Hogdall E, Shah MN, Luben RN, Easton DF, Jacobs IJ, Ponder BA, Whittemore AS, Gayther SA, Pharoah PD, Kruger-Kjaer S: STK15 polymorphisms and association with risk of invasive ovarian cancer. Cancer Epidemiol Biomarkers Prev 2004, 13:1589-1594.
25. Day N, Oakes S, Luben R, Khaw KT, Bingham S, Welch A, Wareham N: EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 1999, 80 Suppl 1:95-103.
26. Stram DO, Haiman CA, Hirschhorn JN, Altshuler D, Kolonel LN, Henderson BE, Pike MC: Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. Hum Hered 2003, 55:27-36.
27. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA: Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002, 70:425-434.
28. Ding K, Zhou K, He F, Shen Y: LDA - a java-based linkage disequilibrium analyzer. Bioinformatics 2003, 19:2147-2148.
29. Armitage P, Berry G: The size of a statistical investigation. In Statistical Methods in Medical Research Volume 6.6. 3rd edition edition. Oxford, Blackwell Scientific Publications; 1994:195-206.
30. Cox DG, Hankinson SE, Kraft P, Hunter DJ: No association between GPX1 Pro198Leu and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2004, 13:1821-1822.
31. Zondervan KT, Cardon LR: The complex interplay among factors that influence allelic association. Nat Rev Genet 2004, 5:89-100.
32. Ahmadi KR, Weale ME, Xue ZY, Soranzo N, Yarnall DP, Briley JD, Maruyama Y, Kobayashi M, Wood NW, Spurr NK, Burns DK, Roses AD, Saunders AM, Goldstein DB: A single-nucleotide polymorphism tagging set for human drug metabolism and transport. Nat Genet 2005, 37:84-89.
33. Klein B, Weirich G, Brauch H: DHPLC-based germline mutation screening in the analysis of the VHL tumor suppressor gene: usefulness and limitations. Hum Genet 2001, 108:376-384.
34. CHEK2*1100delC and Susceptibility to Breast Cancer: A Collaborative Analysis Involving 10,860 Breast Cancer Cases and 9,065 Controls from 10 Studies. Am J Hum Genet 2004, 74:1175-1182.
35. Rebbeck TR, Martinez ME, Sellers TA, Shields PG, Wild CP, Potter JD: Genetic variation and cancer: improving the environment for publication of association studies. Cancer Epidemiol Biomarkers Prev 2004, 13:1985-1986.
36. Colhoun HM, McKeigue PM, Davey SG: Problems of reporting genetic associations with complex outcomes. Lancet 2003, 361:865-872.
37. Cui J, Zhou X, Chazaro I, DeStefano AL, Manolis AJ, Baldwin CT, Gavras H: Association of polymorphisms in the promoter region of the PNMT gene with essential hypertension in African Americans but not in whites. Am J Hypertens 2003, 16:859-863.
38. Ioannidis JP, Ntzani EE, Trikalinos TA: 'Racial' differences in genetic effects for complex diseases. Nat Genet 2004, 36:1312-1318.